Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

JANUARY 24, 2022

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of world-renowned cannabis genetics and cultivation expert Derek Pedro as an advisor to its Cosechemos cultivation facility.

Cultivation 52

Cultivation Wellness and Beauty Research and Development Events 52

Cannabis Law Report

JULY 22, 2021

North Macedonia’s government expects the cannabis cultivation business, which Prime Minister Zoran Zaev says is “very profitable”, to create more jobs and to boost the country’s GDP by an estimated €250mn annually. BNE Intelli News.

Cultivation 105

Cultivation Pharmaceutical Media Cannabis 105

Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

Cannabis Law Report

JANUARY 16, 2020

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this. About Devonian.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Cannabis Law Report

MAY 30, 2019

(CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

Cannabis Law Report

FEBRUARY 23, 2020

Clever Leaves , a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has now launched its new direct-to-business sales platform which offers pharmaceutical-grade cannabis extracts and finished products fit for a broad range of industries.

Extraction 59

Extraction Supply Chain Business Pharmaceutical 59

Cannabis Law Report

AUGUST 1, 2021

GREEK businesses are preparing for amendments to the Mediterranean country’s cannabis laws allowing the cultivation, sale and export of high percentage THC medical products. Tetrahydrocannabinol (THC). Tetrahydrocannabinol (THC).

Sativa 105

Sativa Pharmaceutical Extraction Cultivation 105

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. About Applied DNA Sciences Inc.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. Here’s the press release. All intellectual property from the trials will be owned by MGC, which is funding the research.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Cannabis Law Report

JULY 21, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 19, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. About RAMM Pharma Corp. g, Poland (60 kilometres east of Gda?sk), HemPoland S.p.a.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Cannabis Law Report

JUNE 4, 2020

Million Square Feet of Greenhouses, Clever Leaves is One of the Largest Cannabis Cultivation and Extraction Companies in the World- CORRECTION…by … Read More. -With More than 1.9

Pharmaceutical 59

Pharmaceutical Extraction Cultivation Business 59

Cannabis Law Report

OCTOBER 19, 2019

Freyherr International has 20 hectares of hemp cultivation in its home country and two hectares of medical cannabis growing in North Macedonia, which legalised medical cannabis in 2016. They moved from the Czech Republic to Slovenia where they became recognized as pioneers in pharmaceuticals. pharmaceuticals business Freyherr d.o.o.

Cultivation 45

Cultivation Hemp Research and Development Pharmaceutical 45

Cannabis Law Report

JULY 2, 2021

CannaVerde Pharma is a vertically integrated medical cannabis company with core operations in Colombia, focused on delivering low-cost, pharmaceutical grade, EU-GMP compliant cannabis-based products to consumers and medical patients in Latin America and Europe. July 28th, 2021. 12pm PST / 2pm CST / 3pm EST. CannaVerde Pharma.

Sleep 105

Sleep Pharmaceutical THC Extraction 105

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

APRIL 29, 2022

The Berlin-based company has a Fast Track Access platform that enables producers worldwide to become part of the German market and focuses on long-term collaborations and carries products such as dried flowers, extracts, Dronabinol and pharmaceutical-grade CBD.

Pharmaceutical 59

Pharmaceutical Cultivation Extraction Patients 59

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

AUGUST 26, 2019

ASX-listed MGC Pharmaceuticals has partnered with the Slovenian Institute of Hop Research and Brewing, or “IHPS”, to carry out a ground-breaking, large-scale research project on the use of cannabis for medical purposes. Read the full story at [link].

Research and Development 45

Research and Development Pharmaceutical Extraction Cultivation 45

Cannabis Law Report

AUGUST 19, 2021

Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada.

Medicine 98

Medicine Research and Development Therapy Pharmaceutical 98

Veriheal

JANUARY 25, 2022

Thanks to the 2018 Farm Bill, industrial hemp cultivation and processing is federally legal, though a few states have chosen to ban or not regulate the crop and its derivatives. The statement confirms that the farm bill did not legalize products made with CBD extracted from hemp. A Threat to a Growing Industry. According to U.S.

Hemp 98

Hemp Business CBD Seed-To-Sale 98

Miss Marijuana

NOVEMBER 4, 2020

The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. Ilera Healthcare is one of Pennsylvania’s premier medical marijuana cultivators, processors and dispensers. Cresco cultivates select strains but only harvests the top 10%. MPX – Melting Point Extracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Cannabis Law Report

JULY 22, 2022

The Mildura GMP Licence enables Cann to manufacture Active Pharmaceutical Ingredients (API), hard capsules, Satipharm capsules for human therapeutic use, and perform in-house chemical, physical, and microbiological tests. In March 2017, Cann Group was issued Australia’s first Medicinal Cannabis Cultivation Licence.

Cultivation 52

Cultivation Medicine Pharmaceutical Extraction 52

SpeedWeed

MARCH 9, 2021

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products – and six more products to follow. Hesse-based Stada, Germany’s fifth largest pharmaceutical company, announced late last year it had entered into an agreement with Canadian firm MediPharm Labs.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52

Cannabis Law Report

APRIL 11, 2022

Plant-touching verticals such as cultivation, extraction, manufacturing and/or retail need experts from other industries to adapt, extend, and expand best practices into the highly regulated cannabis market.” – Rowan University, Cannabis Commercialization Concentration Coursework. Read more at [link].

Research and Development 52

Research and Development Policy Decriminalization Pharmaceutical 52

Cannabis Law Report

JULY 24, 2021

With full government approval through Health Canada for exclusive access to a full cGMP-certified pharmaceutical manufacturing facility, Mydecine continues to advance the clinical progress in its 4 leading novel compounds, MYCO-001 through 004 with the ability to import or export, cultivate, extract or isolate, and analyze active mushroom compounds.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

MAY 9, 2022

The Greek Parliament voted in favor of a bill to legalise the cultivation and sale of medical marijuana in Greece on Friday. The bill is labelled “Production, extraction and distribution of final products of pharmaceutical cannabis of the species Cannabis Sativa L, containing over 0.2% The Greek Reporter.

Extraction 52

Extraction Sativa Pharmaceutical Cultivation 52

Cannabis Law Report

DECEMBER 6, 2019

The company has commenced operations at its Southport manufacturing facility in Queensland, considered to be the largest pharmaceutical bio-floral extraction facility in the southern hemisphere. With this milestone achieved, THC intends to move into commercial-scale production early next year. Serving Australian cannabis demand.

Medicine 59

Medicine THC Supply Chain Extraction 59

Cannabis Law Report

DECEMBER 15, 2021

Pharmaceuticals & Medical Devices. Cann Group Limited is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. Educated to a degree level in pharmaceutical, medical or science related subjects.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

MARCH 9, 2022

Pharmaceuticals & Medical Devices. Cann Group Limited is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. Educated to a degree level in pharmaceutical, medical or science related subjects.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

SEPTEMBER 3, 2019

Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

AUGUST 14, 2021

Mary AG’s joint venture Yunnan Moquan and CBDer are currently the only companies licensed for indoor industrial hemp cultivation in China’s only legalized province for cannabinoid extraction. The MOU mainly encompasses: Working with CBDer to further develop China’s industrial hemp market.

Hemp 105

Hemp Supply Chain Cannabinoids Extraction 105

The Cannigma

DECEMBER 4, 2022

Patients can be prescribed medical marijuana in the form of pharmaceuticals, like Sativex. In 2019 , a new draft law for medical marijuana was introduced in the Romanian Parliament that would expand the medical program and allow terminally ill patients to access cannabis flower, extracts, resin, and tinctures, with a maximum THC level of 20%.

Law 59

Law Seed-To-Sale Programs Tincture 59

The Blunt Truth

APRIL 20, 2021

The term does not include industrial hemp, as defined in state law, that is grown, dealt, or processed in compliance with state or federal law, unless it has been acquired and formulated with cannabis plant extract by a pharmaceutical processor. Virginia Recreational Cannabis Law. Retail sales will not begin until January 1, 2024.

Recreational 77

Recreational Legalization Oil Extraction 77